James E. Besser, 10% Owner at FENNEC PHARMACEUTICALS INC. (FENC), bought 51,480 shares at $1.41 ($85K) on 2015-12-15, disclosed to the SEC on 2018-03-29.
Open-market purchase of $85k FENC by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.36 | 1,000 | $2K | 2.8% |
| 2 | $2.30 | 3,180 | $7K | 8.6% |
| 3 | $1.53 | 4,000 | $6K | 7.2% |
| 4 | $1.24 | 900 | $1K | 1.3% |
| 5 | $1.29 | 3,000 | $4K | 4.6% |
| 6 | $1.47 | 5,000 |
| $7K |
| 8.6% |
| 7 | $1.41 | 5,000 | $7K | 8.3% |
| 8 | $1.43 | 2,000 | $3K | 3.4% |
| 9 | $1.52 | 1,000 | $2K | 1.8% |
| 10 | $1.53 | 3,000 | $5K | 5.4% |
| 11 | $1.63 | 3,000 | $5K | 5.8% |
| 12 | $1.66 | 200 | $332 | 0.4% |
| 13 | $1.76 | 10,000 | $18K | 20.7% |
| 14 | $1.85 | 1,100 | $2K | 2.4% |
| 15 | $1.76 | 9,100 | $16K | 18.8% |
| Total | $1.65 avg | 51,480 | $85K | 100% |
| Filing → |
| PCSA | SELL | 2021-02-22 | $574K | — | Filing → |
| PCSA | BUY | 2020-10-13 | $121K | — | Filing → |
| MFST | BUY | 2019-05-02 | $7K | — | Filing → |